Non categorizzato Emergent Biosolutions soars 16% after FDA panel call Febbraio 15, 2023 0 commenti Emergent BioSolutions Inc.’s shares surged over 16% in extended trading on Wednesday after advisory committees for the United States Food and Drug Administration recommended selling its nasal spra… About the author:
Get involved!
Comments